Galera Therapeutics Short Interest Ratio and Short Volume

Galera Therapeutics (NASDAQ:GRTX) Short Interest Frequently Asked Questions

What is Galera Therapeutics' current short interest?

Short interest is the volume of Galera Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 645,000 shares of GRTX short. 6.16% of Galera Therapeutics' shares are currently sold short. Learn More on Galera Therapeutics' current short interest.

What is a good short interest percentage for Galera Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.16% of Galera Therapeutics' floating shares are currently sold short.

Is Galera Therapeutics' short interest increasing or decreasing?

Galera Therapeutics saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 645,000 shares, a decline of 57.6% from the previous total of 1,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Galera Therapeutics' float size?

Galera Therapeutics currently has issued a total of 26,439,000 shares. Some of Galera Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galera Therapeutics currently has a public float of 10,470,000 shares.

How does Galera Therapeutics' short interest compare to its competitors?

6.16% of Galera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Galera Therapeutics: OptiNose, Inc. (6.00%), NuCana plc (2.65%), Atreca, Inc. (13.48%), Enlivex Therapeutics Ltd. (0.00%), Savara Inc (1.98%), Puma Biotechnology, Inc. (7.24%), Clever Leaves Holdings Inc. (0.00%), Tyme Technologies, Inc. (2.70%), Palatin Technologies, Inc. (2.27%), and Concert Pharmaceuticals, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Railway Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short Galera Therapeutics stock?

Short selling GRTX is an investing strategy that aims to generate trading profit from Galera Therapeutics as its price is falling. Galera Therapeutics' stock is trading down $0.05 today. To short Galera Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Galera Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Galera Therapeutics?

A short squeeze for Galera Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GRTX, which in turn drives the price of the stock up even further.

How often is Galera Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRTX, twice per month. The most recent reporting period available is November, 15 2021.